DGAP-News
Airbion GmbH: Airbion: German company challenges COVID-19 viruses and other ultrafine particles - Seite 4
About Airbion
Airbion is a provider of innovative technologies and devices with which respiratory and ambient air are purified by removing ultrafine particles and viruses. To do so, the patented, unique VAPUR technology is used which combines ultrasonic waves, UV-C waves and ultraheating. In this way, Airbion can remove ultrafine particles, viruses and bacteria from the air without contaminants and is clearly superior to conventional filter solutions. Airbion was founded by scientists and top industry managers. The company has its head office in Rellingen; the Airbion devices have been produced and internationally distributed in Gronau (North Rhine-Westphalia) since 2020. More information available on www.airbion.com
Press Contact
edicto GmbH
Ralf Droz/ Svenja Liebig
Eschersheimer Landstraße 42
60322 Frankfurt am Main
Lesen Sie auch
Phone: +49 (0) 69 905505-54
Mail: airbion@edicto.de
01.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: | English |
Company: | Airbion GmbH |
Adlerstraße 77a | |
25462 Rellingen | |
Germany | |
Phone: | +49 4101 85467 70 |
E-mail: | info@airbion.com |
Internet: | www.airbion.com |
EQS News ID: | 1171773 |
End of News | DGAP News Service |
|
1171773 01.03.2021